Read the latest RCOphth news updates and guidance here.
Ophthalmology is one of the first specialities in the UK to use a novel method of updating its original research priorities published in 2013 – Sight and Vision Loss Report.
Andy Pyott carried out extensive interviews in 2020, both virtually and face to face with all the relevant stakeholders to map out the existing provision of services, barriers and good practices.
In Review is a free preprint service from Research Square, developed together with Eye’s publishing partner, Springer Nature, to provide journal-integrated preprint sharing and transparency into the peer review process for authors.
Ophthalmology is one of the first specialities in the UK to use a novel method of updating its original research priorities published in 2013 - Sight and Vision Loss Report.
In this episode, we speak with Sohaib Rufai, an NIHR Doctoral Fellow and Academic Ophthalmology Registrar, about his work in Leicester and Great Ormond Street Hospital using handheld OCT in children with rare diseases.
RCOphth would like to congratulate Professor Gus Gazzard at Moorfields Eye Hospital Foundation Trust for winning the Nettleship Medal for the best-published paper.
RCOphth would like to congratulate Dr Sohaib Riyaz Rufai and his colleagues at The University of Leicester Ulverscroft Eye Unit, & Great Ormond Street Hospital for Children, London for winning the Ulverscroft David Owen prize for the best published paper titled
The purpose of this research award is to facilitate research into the improvement of the management of glaucoma. Applicants may be trainees seeking support for a fellowship or senior researchers seeking a grant for a project. Applications are invited from departments and individuals based in the UK and Ireland, but the research studies may be carried out elsewhere.
The Royal College of Ophthalmologists is pleased to publish revised guidance on the treatment of Retinopathy of prematurity (ROP). ROP is a potentially blinding condition affecting low gestation and very low birth weight infants. Worldwide, it is a major cause of preventable blindness.
Monday 28 February is Rare disease day, a day for raising awareness and generating change for the 300 million people worldwide living with a rare disease, their families and carers. This year the British Ophthalmological Surveillance Unit will celebrate 25 years of rare disease surveillance so today seemed a good opportunity to recognise how this globally unique research unit has impacted the treatment and management of many rare eye conditions. The BOSU has supported over 80 high impact studies of excellent quality that have broadened knowledge and understanding and brought benefit for patients across ophthalmic subspecialties and demographics.
